Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dakota Gold Corp.DC · Entity 5130 | Director | June 01, 2026 | June 03, 2026 |
| Quorum Health CorpQHC · Entity 149783 | Director | May 31, 2019 | June 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dakota Gold Corp.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 362,732 |
Reported balance
After 2026-06-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 17,362 · Balance 362,732 F1: Represents restricted stock units ("RSUs") granted under the Issuer's 2022 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs are scheduled to vest on June 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted under the Issuer's 2022 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs are scheduled to vest on June 1, 2027.
Quorum Health Corp
Report date May 31, 2019 · Filed June 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 64,108 |
Reported balance
After 2019-05-31 transaction · row 1
1 source rowRow 1 · 2019-05-31 · Grant · Acquired 43,478 · Balance 64,108 F1: On May 31, 2019, the reporting person received a grant of 43,478 shares of restricted common stock pursuant to the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. 100% of the number of shares of restricted stock issued shall vest, and the restrictions with respect to such restricted stock shall lapse, on February 14, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 31, 2019, the reporting person received a grant of 43,478 shares of restricted common stock pursuant to the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. 100% of the number of shares of restricted stock issued shall vest, and the restrictions with respect to such restricted stock shall lapse, on February 14, 2020.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NATUS MEDICAL INC
Report date July 21, 2022 · Filed July 21, 2022
Section 16 reporting ended · disclosed 2022-07-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-21 transaction · row 1
1 source rowRow 1 · 2022-07-21 · Disposition to issuer · Disposed 22,406 · Balance 0 F1: Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement"). F2: Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement").
F2: Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 16:54 UTC | Dakota Gold Corp. DC · Entity 5130 | GrantCOMMON STOCK | 17,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-070016 · tm2616571-5_4seq1.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,732 F1 · security: Represents restricted stock units ("RSUs") granted under the Issuer's 2022 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs are scheduled to vest on June 1, 2027. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:01 UTC | Dakota Gold Corp. DC · Entity 5130 | OtherWARRANTS · Derivative | 9,018 | $0.00 Strike: $2.08 | $0.00 |
DisclosureSEC source: 0001104659-26-029439 · tm269013-1_4seq1.xml · derivative · entry 2 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: COMMON STOCK · 9,018 shares Expires 2026-03-15 Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:01 UTC | Dakota Gold Corp. DC · Entity 5130 | OtherCOMMON STOCK | 9,018 | $2.08 | $18,757.44 |
DisclosureSEC source: 0001104659-26-029439 · tm269013-1_4seq1.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,370 Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 23:52 UTC | Dakota Gold Corp. DC · Entity 5130 | GrantCOMMON STOCK | 33,003 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004674 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,352 F1 · security: Represents restricted stock units ("RSUs") granted under the Issuer's 2022 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs are scheduled to vest in three equal tranches on March 1, 2026, March 1, 2027 and March 1, 2028. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 20:52 UTC | Dakota Gold Corp. DC · Entity 5130 | GrantCommon Stock | 47,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005443 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,349 F1 · shares: Represents restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of Dakota Gold Corp. common stock. The RSUs are scheduled to vest in three equal tranches on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 20:22 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 7,410 | $1.96 | $14,521.38 |
DisclosureSEC source: 0001062993-24-004426 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,179 Read SEC document |
| May 26, 2023 Filed May 30, 2023 22:09 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 1,373 | $3.12 | $4,283.76 |
DisclosureSEC source: 0001062993-23-012478 · form4.xml · nonDerivative · entry 2 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,769 Read SEC document |
| May 26, 2023 Filed May 30, 2023 22:09 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 25,000 | $3.13 | $78,250.00 |
DisclosureSEC source: 0001062993-23-012478 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,396 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 19:35 UTC | Dakota Gold Corp. DC · Entity 5130 | GrantCommon Stock | 35,587 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005800 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,396 F1 · shares: Represents restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of Dakota Gold Corp. common stock. The RSUs are scheduled to vest in three equal tranches on March 1, 2024, March 1, 2025 and March 1, 2026. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 20:49 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 20,000 | $2.80 | $56,000.00 |
DisclosureSEC source: 0001062993-23-005082 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,809 Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 23:27 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 20,000 | $2.96 | $59,200.00 |
DisclosureSEC source: 0001062993-23-004298 · form4.xml · nonDerivative · entry 2 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,809 Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 23:27 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 44 | $3.00 | $132.00 |
DisclosureSEC source: 0001062993-23-004298 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,809 Read SEC document |
| December 19, 2022 Filed Dec 19, 2022 23:14 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 10,000 | $2.87 | $28,700.00 |
DisclosureSEC source: 0001062993-22-024161 · form4.xml · nonDerivative · entry 4 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,765 Read SEC document |
| December 19, 2022 Filed Dec 19, 2022 23:14 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 10,000 | $2.89 | $28,900.00 |
DisclosureSEC source: 0001062993-22-024161 · form4.xml · nonDerivative · entry 3 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,765 Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 23:14 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 21,995 | $3.01 | $66,204.95 |
DisclosureSEC source: 0001062993-22-024161 · form4.xml · nonDerivative · entry 2 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,765 Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 23:14 UTC | Dakota Gold Corp. DC · Entity 5130 | PurchaseCommon Stock | 20,000 | $3.03 | $60,600.00 |
DisclosureSEC source: 0001062993-22-024161 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,770 Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 21:01 UTC | Dakota Gold Corp. DC · Entity 5130 | GrantStock Options · Derivative | 100,000 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0001062993-22-019326 · form4.xml · derivative · entry 2 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-09-02 F2 · derivative.exercise_date: The options are scheduled to vest in three equal tranches on September 2, 2022, September 2, 2023 and September 2, 2024. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 21:01 UTC | Dakota Gold Corp. DC · Entity 5130 | GrantCommon Stock | 13,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019326 · form4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,770 F1 · shares: Represents restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of Dakota Gold Corp. common stock. The RSUs are scheduled to vest on May 11, 2023 Read SEC document |
| July 21, 2022 Filed Jul 21, 2022 17:25 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | Disposition to issuerCommon Stock, $0.001 par value per share | 22,406 | $33.50 | $750,601.00 |
DisclosureSEC source: 0000878526-22-000102 · wf-form4_165843869060053.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement"). F2 · price: Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:57 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | GrantCommon Stock, $0.001 par value per share | 5,075 | $0.00 | $0.00 |
DisclosureSEC source: 0000878526-22-000051 · wf-form4_165549941964603.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,406 F1 · shares: The shares vest in full on the first anniversary of the date of the award. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 17:05 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | GrantCommon Stock, $0.001 par value per share | 5,214 | $28.77 | $150,006.78 |
DisclosureSEC source: 0000878526-21-000063 · wf-form4_162430950817896.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,331 F1 · shares: The shares vest in full on the first anniversary of the date of the award. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 17:05 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | SaleCommon Stock, $0.001 par vale per share | 2,934 | $27.49 | $80,655.66 |
DisclosureSEC source: 0000878526-21-000055 · wf-form4_162379110994683.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,117 F1 · shares: The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| June 19, 2020 Filed Jun 22, 2020 17:12 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | GrantCommon Stock, $0.001 par vale per share | 7,120 | $21.07 | $150,018.40 |
DisclosureSEC source: 0000878526-20-000065 · wf-form4_159286031904212.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,051 F1 · shares: The shares vest in full on first anniversary of the date of the award. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 17:18 UTC | NATUS MEDICAL INC BABY · Entity 125256 | GrantCommon Stock, $0.001 par vale per share | 2,923 | $25.66 | $75,004.18 |
DisclosureSEC source: 0000878526-19-000102 · wf-form4_156210232102349.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,931 F1 · shares: The shares vest in full on first anniversary of the date of the award. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 21:24 UTC | Quorum Health Corp QHC · Entity 149783 | GrantCommon stock, par value $0.0001 per share | 43,478 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-008612 · ownership.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,108 F1 · shares: On May 31, 2019, the reporting person received a grant of 43,478 shares of restricted common stock pursuant to the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. 100% of the number of shares of restricted stock issued shall vest, and the restrictions with respect to such restricted stock shall lapse, on February 14, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:41 UTC | NATUS MEDICAL INC BABY · Entity 125256 | GrantCommon Stock, $0.001 par vale per share | 5,008 | $29.95 | $149,989.60 |
DisclosureSEC source: 0000878526-19-000034 · wf-form4_155009766458915.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,008 F1 · shares: The shares vest in full on first anniversary of the date of the award. Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 17:45 UTC | Quorum Health Corp QHC · Entity 149783 | GrantCommon stock, par value $0.0001 per share | 20,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052616 · doc4.xml · nonDerivative · entry 2 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,630 F1 · kind: On September 27, 2018, Quorum Health Corporation (the "Issuer") and the reporting person entered into an Acknowledgement of Award Cancellation cancelling the July 5, 2018 award of 20,630 shares of restricted common stock because it was issued in excess of the limitations under the Issuer's 2016 Stock Award Plan. Thereafter, the Issuer re-granted to the reporting person 20,630 shares of restricted common stock pursuant to the Issuer's 2016 Stock Award Plan. F2 · shares: 100% of the number of shares of restricted common stock issued shall vest on March 9, 2019. F1 · acquired: On September 27, 2018, Quorum Health Corporation (the "Issuer") and the reporting person entered into an Acknowledgement of Award Cancellation cancelling the July 5, 2018 award of 20,630 shares of restricted common stock because it was issued in excess of the limitations under the Issuer's 2016 Stock Award Plan. Thereafter, the Issuer re-granted to the reporting person 20,630 shares of restricted common stock pursuant to the Issuer's 2016 Stock Award Plan. Read SEC document |
| September 27, 2018 Filed Sep 28, 2018 17:45 UTC | Quorum Health Corp QHC · Entity 149783 | OtherCommon stock, par value $0.0001 per share | 20,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-052616 · doc4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On September 27, 2018, Quorum Health Corporation (the "Issuer") and the reporting person entered into an Acknowledgement of Award Cancellation cancelling the July 5, 2018 award of 20,630 shares of restricted common stock because it was issued in excess of the limitations under the Issuer's 2016 Stock Award Plan. Thereafter, the Issuer re-granted to the reporting person 20,630 shares of restricted common stock pursuant to the Issuer's 2016 Stock Award Plan. F1 · acquired: On September 27, 2018, Quorum Health Corporation (the "Issuer") and the reporting person entered into an Acknowledgement of Award Cancellation cancelling the July 5, 2018 award of 20,630 shares of restricted common stock because it was issued in excess of the limitations under the Issuer's 2016 Stock Award Plan. Thereafter, the Issuer re-granted to the reporting person 20,630 shares of restricted common stock pursuant to the Issuer's 2016 Stock Award Plan. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 10:20 UTC | Quorum Health Corp QHC · Entity 149783 | GrantCommon stock, par value $0.0001 per share | 20,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-041825 · doc4.xml · nonDerivative · entry 1 SCHROEDER ALICE D. · CIK 0001743916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,630 F1 · shares: On July 5, 2018, the reporting person received a grant of 20,630 shares of restricted common stock pursuant to the Quorum Health Corporation 2016 Stock Award Plan. 100% of the number of shares of restricted stock issued shall vest, and the restrictions with respect to such restricted stock shall lapse, on March 9, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.